NOVOTECH CLINICAL RESEARCH (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

NOVOTECH CLINICAL RESEARCH (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Copy
copy info iconCopy

Key data

Status

Active

KRS number

0000331350Copy
copy info iconCopy

REGON

14188798500000Copy
copy info iconCopy

NIP/VAT code

5272601638Copy
copy info iconCopy

VAT registration date

18/08/2009

VAT status

Active

Bankruptcy proceedings

No proceedings

NOVOTECH CLINICAL RESEARCH (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

Registered address

UL. MARSZAŁKOWSKA 142, 00-061, WARSZAWA, POLSKACopy
copy info iconCopy
See on map
Website

Website

-
None Pie Chart
no data iconNot calculated
Highest reliabilityLowest reliability

Reliability

A - Highest
B - High
C - Average
D - Low
E - Lowest
alter icon

Prescore cannot be calculated because the company delayed submission of financial statements.

Incorporation date

15/06/2009

Share capital

5,000.00 PLN

Primary activity

Other research and experimental development on natural sciences and engineering (72.19.Z - PKD 2007)

Representatives

1

Representatives rights

1. SPÓŁKĘ REPREZENTUJE KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE

Representatives

dot
Member of the management boardK******** S******** L*******

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

1
Personsort default icon
Titlesort default icon
K******** S******** L*******
Member of the management board

Persons with Significant Control

1
psc login icon

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

€

Net Profit (zł)

343,128

Net Profit (zł)

343,128

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit
Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%)
info iconThe working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio
info iconliquidityRatio
Net profitability (%)
info iconThis ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)
2021
7,120,355
287,919
253,038
0.07
2.38
3.55
3,362,658
376,388
0
-
2022
12,206,102
491,284
343,128
0.07
2.71
2.81
3,705,785
465,203
0
-
2022
12,206,102
491,284
343,128
0.07
2.71
2.81
3,705,785
465,203
0
-

Turnover (zł)

2022

Turnover (zł)

12,206,102 złAscended71 % *

Profit before tax (zł)

491,284 złAscended71 % *

Net Profit (zł)

343,128 złAscended36 % *

Working capital requirement (%)

0.07 Ascended0.00 % *

Liquidity ratio

2.71 Ascended13.87 % *

Net profitability (%)

2.81 %Descended-20.85 % *

Equity (zł)

3,705,785 złAscended10 % *

Current liabilities (zł)

465,203 złAscended24 % *

Non current liabilities (zł)

0 złAscended- *

Non-current Assets (zł)

-
*over the last year starting selected period

Credit history

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

No. of unpaid debts

0

Largest debt

-

Amount of unpaid debts

€0.00

Oldest open debt

-

Credit report

Price: 1.00 credit
Unpaid debts
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Debt typesort default icon
-
-
-
-
Debt payment history
locked icon
Creditor/Data sourcesort default icon
Debt amountsort default icon
Debt datesort default icon
Payment datesort default icon
Debt typesort default icon
-
-
-
-
-

Documents

NOVOTECH CLINICAL RESEARCH (POLAND) SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

16
Datesort default icon
Descriptionsort default icon
20/08/2025
OD 01.01.2024 DO 31.12.2024
27/05/2024
OD 01.01.2023 DO 31.12.2023
29/03/2023
OD 01.01.2022 DO 31.12.2022
25/05/2022
OD 01.01.2021 DO 31.12.2021
21/06/2021
OD 01.01.2020 DO 31.12.2020